A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: A case-control study and meta-analysis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Duan, Jiayu ^a   Lou, Jiao ^a   Zhang, Qing ^b   Ke, Juntao ^a   Qi, Yanqi ^b   Shen, Na ^a   Zhu, Beibei ^a   Zhong, Rong ^a   Wang, Zhenling ^a   Liu, Lifeng ^a   Wu, Jing ^a   Wang, Wei ^b   Gong, Fangqi ^b   Miao, Xiaoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN FCGR2A; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FC RECEPTOR; FCGR2A PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FCGR2A GENE; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; RECEPTOR GENE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; METABOLISM; PRESCHOOL CHILD; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; RISK FACTORS;

EID: 84905506978     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103329     Document Type: Article

References (51)

1. Kawasaki T (1967) [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 16: 178-222.
2. Rowley AH, Baker SC, Orenstein JM, Shulman ST (2008) Searching for the cause of Kawasaki disease-cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol 6: 394-401. (Pubitemid 351552660)
3. Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22: 79-85.
4. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, et al. (2008) Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int 50: 287-290. (Pubitemid 351781496)
5. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, et al. (2009) Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 123: e401-405.
6. Fimbres AM, Shulman ST (2008) Kawasaki disease. Pediatr Rev 29: 308-316.
7. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, et al. (2005) Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 47: 232-234.
8. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, et al. (1993) Diagnosis and therapy of Kawasaki disease in children. Circulation 87: 1776-1780. (Pubitemid 23133135)
9. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110: 2747-2771. (Pubitemid 39453026)
10. Burns JC, Glodé MP (2004) Kawasaki syndrome. The Lancet 364: 533-544. (Pubitemid 39070416)
11. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, et al. (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324: 1633-1639.
12. Tse SML, Silverman ED, McCrindle BW, Yeung RSM (2002) Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 140: 450-455. (Pubitemid 34494318)
13. Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, et al. (1989) Kawasaki disease in families. Pediatrics 84: 666-669. (Pubitemid 19237567)
14. Holman RC, Curns AT, Belay ED, Steiner CA, Effler PV, et al. (2005) Kawasaki syndrome in Hawaii. Pediatr Infect Dis J 24: 429-433. (Pubitemid 40664238)
15. Burns JC, Newburger JW (2012) Genetics insights into the pathogenesis of Kawasaki disease. Circ Cardiovasc Genet 5: 277-278.
16. Uehara R, Yashiro M, Nakamura Y, Yanagawa H (2003) Kawasaki disease in parents and children. Acta Paediatr 92: 694-697. (Pubitemid 37088678)
17. Park YW, Han JW, Hong YM, Ma JS, Cha SH, et al. (2011) Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr Int 53: 36-39.
18. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, et al. (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 22: 216-221.
19. Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, et al. (2011) A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 129: 487-495.
20. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, et al. (2009) A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 5: e1000319.
21. Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, et al. (2011) Identification of novel susceptibility loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PLoS One 6: e16853.
22. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, et al. (2011) Genomewide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43: 1241-U1104.
23. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, et al. (2012) A genomewide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44: 517-521.
24. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, et al. (2012) Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 44: 522-525.
25. Pleass RJ, Woof JM (2001) Fc receptors and immunity to parasites. Trends Parasitol 17: 545-551. (Pubitemid 34185362)
26. Gerber JS, Mosser DM (2001) Stimulatory and inhibitory signals originatingfrom the macrophage Fcc receptors. Microbes Infect 3: 131-139. (Pubitemid 32209330)
27. Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210. (Pubitemid 351171405)
28. Nimmerjahn F (2006) Activating and inhibitory FccRs in autoimmune disorders; 2006. Springer. pp. 305-319.
29. Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, et al. (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 41: 1325-1329.
30. Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121: 689-694.
31. Arjunan K, Daniels SR, Meyer RA, Schwartz DC, Barron H, et al. (1986) Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J Am Coll Cardiol 8: 1119-1124. (Pubitemid 16009098)
32. Kazeem GR, Farrall M (2005) Integrating case-control and TDT studies. Ann Hum Genet 69: 329-335. (Pubitemid 40613734)
33. Peterman RM (1995) Statistical power of methods of meta-analysis. Trends Ecol Evol 10: 460.
34. Nicodemus KK (2008) Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 9: 130.
35. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306. (Pubitemid 40585169)
36. Yan Y, Ma Y, Liu Y, Hu H, Shen Y, et al. (2013) Combined analysis of genome-wide- linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet 1-12.
37. Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, et al. (2005) Polymorphism of Fcc RIIa may affect the efficacy of c-globulin therapy in Kawasaki disease. J Clin Immunol 25: 309-313.
38. Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, et al. (2007) The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol 147: 106-111. (Pubitemid 44915561)
39. Ji YX, Zhang HY, Lin SX (2013) [Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease]. Zhongguo Dang Dai Er Ke Za Zhi 15: 196-200.
40. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ (1991) A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147: 1338-1343.
41. Shrestha S, Wiener H, Olson AK, Edberg JC, Bowles NE, et al. (2011) Functional FccRIIB Gene Variants Influence Intravenous Immunoglobulin (IVIG) Response in Kawasaki Disease (KD) Patients. J Allergy Clin Immunol 128: 677.
42. Schneider MP, Leusen JH, Herrmann M, Garlichs CD, Amann K, et al. (2011) The Fcgamma receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia. Atherosclerosis 218: 411-415.
43. Mortensen RF, Osmand AP, Lint TF, Gewurz H (1976) Interaction of Creactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. J Immunol 117: 774-781.
44. Kindmark CO (1971) Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol 8: 941-948.
45. Kilpatrick JM, Volanakis JE (1985) Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells. J Immunol 134: 3364-3370. (Pubitemid 15246479)
46. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW (1995) Creactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 155: 2185-2193.
47. Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, et al. (2000) Creactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 105: 369-376. (Pubitemid 30094457)
48. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39: 632-637. (Pubitemid 34158159)
49. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343: 1139-1147.
50. Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, et al. (2002) C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study. Atherosclerosis 160: 433-440. (Pubitemid 34159338)
51. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565. (Pubitemid 35315836)